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Background: On the basis of the hypothesis that cardioplegia-associated myocardial
depression was due to activation of protein kinase C, we examined whether specific
protein kinase C isozymes would translocate to a cellular fraction containing
myofilaments.
Methods: Isolated rat hearts were perfused with Krebs-Ringer bicarbonate buffer for
30 minutes and arrested with 4°C St Thomas No. 2 cardioplegic solution for 0 to 120
minutes (n 5 per group). The 3 fractions of the left ventricle tissue represented the
myofibrillar/nuclear fraction (P1), membranes (P2), and cytosol (supernatant). The
distributions of protein kinase C isozymes , , , and  were examined after
separation by electrophoresis, immunoblotting/chemiluminescence, and densitom-
etry.
Results: A significant increase in protein kinase C- in the P1 fraction was detected
after 5 minutes of cardioplegic arrest and remained increased for 60 minutes.
Increases in P1 protein kinase C- and - were seen transiently at 5 minutes, and
protein kinase C- demonstrated a secondary increase in P1 at 30 to 60 minutes.
There was also a significant relative increase in protein kinase C- and protein
kinase C- in the P2 fraction after 60 minutes of cardioplegia.
Conclusions: These data are consistent with our hypothesis that activation of protein
kinase C isozymes is associated with altered myofilament function after cardioplegic
arrest.
Stable patients presenting for elective heart operations (eg, coronarybypass surgery) usually face a low risk of perioperative morbidity andmortality. However, cardiac surgery is being performed on increas-ingly unstable, complex patients who have other risks, such as ad-vanced age or additional illnesses. Patients with poor left ventricularfunction and diabetic patients have been identified as those who could
benefit from improved cardioprotective techniques.1,2 Ventricular dysfunction, re-
flected by low systolic and diastolic function and, consequently, low cardiac output,
is one of the major causes for prolonged hospital stay and increased treatment
costs.3,4 The primary mechanism of myocardial depression after cold crystalloid
cardioplegia (CPDL) is still unclear. Many different factors have been identified as
harmful and detrimental, including hypothermia alone, which, although it exerts a
protective effect, can also alter enzyme kinetics and receptor-binding characteristics.
Previous work from our laboratory has demonstrated that altered cellular function
results from the CDPL itself, rather than as a result of reperfusion injury.5 We also
demonstrated that unique isozyme changes in protein kinase C (PKC) may be
involved. The translocation and activation of PKC isozymes during ischemia and
ischemic preconditioning have been associated with protection from ischemic
From the Research Service,a West Side
Veterans Administration Medical Center,
Chicago, Ill, the Department of Physiology
and Biophysics,b University of Illinois at
Chicago, Chicago, Ill, and the Department
of Surgical Nursing,c University of Illinois
at Chicago, Chicago, Ill.
Funding for this work was provided by a
Merit Review grant from the Veterans Ad-
ministration (W.R.L.).
Received for publication Feb 28, 2003; re-
visions requested May 28, 2003; revisions
received June 13, 2003; accepted for pub-
lication July 10, 2003.
Address for reprints: William R. Law, PhD,
University of Illinois at Chicago, Depart-
ment of Physiology and Biophysics (MC
901), 835 S Wolcott Ave, Chicago, IL
60612-7342 (E-mail: wrlaw@uic.edu).
J Thorac Cardiovasc Surg 2003;126:1880-5
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(03)01326-6
Cardiopulmonary Support and Physiology Jonjev et al
1880 The Journal of Thoracic and Cardiovascular Surgery ● December 2003
CSP
injury.6-8 Some isozymes of PKC, however, can have det-
rimental effects on cardiac function.9 Our previous work10
and that of other investigators6,11 has demonstrated that
novel PKC isozymes (, , , and ) may be important in
myocardial signal transduction during CDPL arrest. How-
ever, the timing of events, the category of isozymes, their
location, and the specificity of the response remain unclear.
The aim of this study was to determine when and where
specific PKC isozymes translocate among different subcel-
lular fractions during CDPL arrest.
Materials and Methods
The experiments reported herein were approved by the Animal
Care and Use Committee of the University of Illinois and conform
to the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (Publication No.
85-23, revised 1996).
Isolated Heart Protocol
Male Sprague-Dawley rats (300-400 g) were anesthetized with
sodium pentobarbital (50 mg/kg intraperitoneally). A midline ab-
dominal incision was made, and sodium heparin (200 IU) was
injected into the inferior vena cava. Two minutes after injection of
heparin, the chest was rapidly opened, and the heart was removed
and placed in ice-cold (4°C) Krebs-Ringer bicarbonate buffer.
Extraneous tissue was dissected free, and the aortic root was
rapidly cannulated. The cannula was then connected to a nonre-
circulating, temperature-controlled, isolated heart perfusion appa-
ratus. The heart was perfused with warm (37°C), oxygenated
(95.5% oxygen/4.5% CO2), modified Krebs-Ringer bicarbonate
buffer (pH 7.4) containing 100 mmol/L NaCl, 4.74 mmol/L KCl,
1.12 mmol/L CaCl2, 1.18 MgSO4, 25 mmol/L NaHCO3, and 1.18
mmol/L KH2PO4 and modified with the addition of 11.4 mmol/L
glucose, 4.92 mmol/L pyruvate, and 5.38 mmol/L fumarate. The
hearts were perfused in an aortic retrograde fashion at a constant
pressure of 80 mm Hg and paced at 300 beats/min with bipolar
stainless-steel electrodes embedded in the right atrium.
Research Design
Left ventricular pressures were recorded as previously detailed10,12
via a latex balloon inserted into the left ventricle. The preparation
was considered stable if the diastolic and systolic pressures re-
mained constant (diastolic pressure variation 2 mm Hg and
systolic variation 5 mm Hg) for 15 minutes. Systolic developed
pressure at a preload pressure of 5 mm Hg was used to compare
systolic performance between groups. Each heart was perfused for
30 minutes at 37°C (stabilization period). Exclusion criteria in-
cluded ventricular dysrhythmias, inability to capture pacing of the
heart, or low systolic pressure (60 mm Hg) during the equilibra-
tion period. If any of these criteria were present, the heart was
excluded from the study.
Signal-induced activation and translocation of PKC occurs
rapidly and is followed by the functional response. Translocation
of different PKC isozymes may not occur simultaneously. Thus, to
capture CDPL-elicited changes in isozyme distribution, hearts
undergoing CDPL arrest were quickly frozen in liquid nitrogen
after various durations of arrest. After completion of the protocol,
only the left ventricle was dissected free and quickly frozen in
liquid nitrogen for later assessment of PKC levels in particulate
and cytosolic fractions by immunoblotting, as described below.
Left ventricles from the no-perfusion hearts were frozen immedi-
ately after removal from the chest.
Experimental Groups
Rats were randomly assigned to 1 of 7 experimental groups (n 
5 per group). The first group of hearts was a nonperfused group.
Hearts were taken out of the chest and quickly frozen in the liquid
nitrogen, without perfusion. The other 6 groups of hearts under-
went isolated heart perfusion with Krebs-Ringer bicarbonate
buffer for a 30-minute baseline period. Krebs-Ringer bicarbonate
buffer was oxygenated throughout the procedure with 95.5% ox-
ygen and 4.5% CO2 and maintained at 37°C (pH 7.4). After
baseline perfusion, hearts were arrested with 3 mL of cold, crys-
talloid St Thomas No. 2 cardioplegia (643 mg/L NaCl, 119.3 mg/L
KCl, 17.6 mg/L CaCl2, 325.3 mg/L MgCl2, and 10 mL/L 8.4%
NaHCO3 for pH adjustment to pH 7.8 at 4°C; Abbot Laboratories,
North Chicago, Ill) in a volume of 3 mL. This was repeated every
15 minutes in the amount of 1 mL for up to 120 minutes. The
amount of cardioplegia, time of administration, and duration of
arrest closely simulate the approach taken in the operating room
during heart operations. Groups of hearts at 0, 2.5, 5, 15, 30, and
120 minutes after arrest were rapidly frozen with liquid nitrogen–
cooled aluminum tongs.
Left Ventricle Tissue Preparation
Frozen left ventricular tissue was pulverized with a pestle in an
ice-cold ceramic dish under liquid nitrogen. The powdered tissue
sample was then placed into 9 mL of homogenizing buffer con-
taining 10 mmol/L Tris-HCI, 1 mmol/L ethylene glycol-bis(-
aminoethyl ether)-N,N,N',N'-tetraacetic acid, 350 mmol/L sucrose,
5 mmol/L sodium azide (NaN3), 10 mmol/L mercaptoethanol, 0.02
mmol/L phenylmethylsulphonyl fluoride, 50 mmol/L NaF, 1
g/mL pepstatin, and 1 g/mL leupeptin (pH 7.5 at 4°C) and
homogenized on ice with an Omni Polytron homogenizer (probe
size, 795 mm) 6  10-second bursts separated by 10-second rests.
Differential centrifugation at 1000g (10 minutes; 4°C) and
100,000g (60 minutes; 4°C) yielded pellets representing a myofi-
brillar/nuclear fraction (P1) and nonnuclear membranes (P2), re-
spectively; the supernatant (S) represented the cytosolic fraction.
P1 and P2 pellets were resuspended in homogenizing buffer with
48 and 24 g/mL phenylmethylsulphonyl fluoride, respectively.
The purity of the fractions was determined by distribution of
lactate dehydrogenase, 5'-nucleotidase, or DNA (Sigma Diagnos-
tics, St Louis, Mo).
Immunoblot Analysis of PKC Isozymes
Primary antibodies to PKC isozymes , , , and  were obtained
from Santa Cruz Biotechnology (Santa Cruz, Calif). These anti-
bodies were tested against corresponding, pure PKC isozyme
protein by Western immunoblot analysis. No cross-reactivity be-
tween these isozyme antibodies and other isozymes was seen.
Protein (50 g) from each fraction (P1, P2, and S) was sepa-
rated by standard sodium dodecyl sulfate polyacrylamide (7.5%)
gel electrophoresis at a constant voltage according to the method
of Laemmli,13 and proteins were electrophoretically transferred to
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nitrocellulose membranes (Hybond ECL; Amersham, Arlington
Heights, Ill), as previously described.10 Standard procedures were
used for immunodetection of PKC isozymes by specific antibodies
to PKC , , , or  (Santa Cruz Biotechnology). The identity of
the PKC was confirmed by reported molecular weights and by
comparison to the migration of authentic PKC in rat brain or PKC
isozyme standards (Calbiochem, La Jolla, Calif). Immunoblots
were scanned and quantified by relative optical density by using
the computer software Un-Scan It gel, Automated Digitizing Sys-
tem, version 5.1 (Silk Scientific Corp, Orem, Utah). Optical den-
sities were normalized to stable proteins visualized with Ponceau
stain. The amount of isoforms present in all fractions was ex-
pressed as a percentage of isoforms from the total homogenate,
which represents combined isozymes.
Statistics
All values are presented as means  SEM. Data were analyzed by
2-way analysis of variance. Where the F value indicated signifi-
cance, specific differences were determined by using the Student-
Newman-Keuls post hoc test.
Results
Hemodynamic Data
Left ventricular systolic pressure was measured in the iso-
lated perfused heart at a constant preload of 5 mm Hg
end-diastolic pressure. Systolic pressure measurements
were obtained during the stabilization period at 0, 15, and
30 minutes. There were no statistically significant differ-
ences in developed systolic pressure between the groups at
any point of stabilization.
Subcellular Fraction Purity
The P1 fraction displayed a Western electrophoretic protein
profile identical to that seen for pure, isolated myofila-
ments.14 This profile was not seen in the other fractions. The
P2 fraction was 95% enriched for 5'-nucleotidase; no
significant 5'-nucleotidase activity was measured in either
the P1 or S fractions. The S fraction was95% enriched for
lactate dehydrogenase; no significant lactate dehydrogenase
activity was measured in either the P1 or the P2 fractions.
Evidence of DNA was found in all fractions with no evi-
dence of compartmentalization. This suggested that the nu-
clei were disrupted in the homogenization process.
Change in PKC Isozyme Distribution During
Cardioplegic Arrest
The relative distribution of all PKC isozymes identified in
hearts undergoing the 30-minute equilibration period alone
(0 minutes of CDPL) and in unperfused hearts (fresh frozen
from the chest in situ) were the same. The isozymes were
primarily found in the cytosolic fraction, with 10% in P1
and P2 fractions (Figure 1).
Representative immunoblots for PKC- from 3 time pe-
riods are shown in Figure 1. Densitometric data from all
hearts representing the distribution of PKC isozymes , ,
and  in particulate fractions (P1 and P2) and cytosol (S) are
shown in Figure 2. We identified significant increases in
PKC-, -, and - in the P1 fractions, with a concomitant
decrease in the cytosolic fraction 5 minutes after CDPL
arrest. For PKC-, the increase in P1 was sustained through
60 minutes of CDPL. By 10 minutes, both PKC- and
PKC- returned to a baseline distribution pattern. PKC-
demonstrated translocation to the P1 fraction a second time
from 30 to 60 minutes. There was a small but significant
relative increase in PKC- and PKC- into the P2 fraction
after 60 minutes of CDPL. We were unable to detect PKC-
in any fraction from the rat heart.
By 120 minutes of CDPL arrest, the patterns of distri-
bution for all PKC isozymes were similar to the basal state
(t  0). This most likely reflected the relative loss of PKC
after activation. A decrease in optical densities in particulate
fractions was seen by 120 minutes, but without a concom-
itant increase in cytosolic fraction density (Figure 1). Sim-
ilarly, the total optical density of PKC- showed a signifi-
cant decrease of PKC protein over time (Figure 3),
suggesting that the relative decrease in particulate fraction
PKC and the relative increase in the cytosolic fraction
represented ubiquidation rather than translocation back into
the cytosol.
Discussion
The results of this study indicate that during CDPL, the
PKC-, , and  isozymes translocate, primarily to a portion
of the myocardium represented by the myofilaments. There
was also evidence of a smaller, secondary translocation of
PKC- and  to the fraction containing membranes. Further,
the temporal profiles of these isozyme translocations varied
significantly among the isozymes. This contrasts with re-
sults seen under other conditions, such as warm ischemia
Figure 1. Representative Western blots for PKC- from cardiac
ventricular tissue separated into the particulate fractions P1
(nucleus and myofibrils), P2 (other membranes), S (cytosol), and H
(total homogenate).
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and ischemic preconditioning, as reported by other labora-
tories, and may represent a novel response to cold.
The timing and relative quantity of subcellular redistri-
bution of PKC isozymes during CDPL arrest were unique
for each of the isozymes visualized. All isozymes visualized
translocated to the fraction containing myofilament proteins
at 5 minutes. This was sustained for a longer period of time
only by the PKC- isozyme, although a secondary increase
in PKC- to the P1 fraction was evident between 30 and 60
minutes. Some investigators have used similar fractionation
techniques, but they limited their observations to cytosolic
and membrane fractions.7 Still others were exploring dif-
ferent conditions, which highlights how different the
changes are that we found to be associated with CDPL.
With regard to the isozymes involved, the sites of translo-
cation, and the timing of events, our data differ significantly
from those reported in warm ischemia15 or ischemic pre-
conditioning.16 Yoshida and colleagues15 demonstrated the
presence and translocation of PKC- from the cytosolic
fraction to both the P1 and P2 fractions during warm isch-
emia. Our results differ in that PKC- translocated early and
transiently. The involvement of translocation to the P2
fraction that we observed was also much more limited and
may be artifactual because of the ubiquidation of the
isozyme earlier associated with the P1 fraction. Similar
distinctions between the work of Yohida and colleagues and
our data were evident regarding the translocation of PKC-
and -. In distinct contrast to our findings, Ping and col-
leagues6 reported translocation of only PKC- after isch-
emic preconditioning and found no evidence of involvement
for PKC- or -. The PKC- isozyme has been detected in
rabbit hearts, and there has been some suggestion that
PKC- might have an important role in myocardial protec-
tion in ischemic preconditioning.16 However, we could not
detect PKC- at baseline or at any time after CDPL arrest.
The cardioplegic approach we used consistently results
in a measurable ventricular contractile deficit.10,12,14 The
pathophysiology underlying cardioplegia-related ventricular
dysfunction is complex.17-20 Various experimental models
of heart dysfunction have demonstrated that impaired myo-
cardial performance is associated with changes in the dis-
tribution of PKC.10,15,21 Furthermore, Lu and associates7
demonstrated that nonspecific inhibition of all PKC
isozymes attenuates or prevents the protection afforded by
preconditioning of the heart. Other investigators8,22-24 have
done extensive work demonstrating roles for both PKC and
reactive oxygen species in ischemic preconditioning. How-
ever, our evidence indicates that the timing and profile of
isozymes involved differ from those seen in warm ischemia
Figure 2. Subcellular distribution of PKC- (top), - (middle), and
 (bottom) at periods during cardioplegic arrest. *Different from
baseline (t  0 minutes); adifferent from time-matched  value;
ddifferent from time-matched  value; edifferent from time-
matched  value. OD, Optical density.
Figure 3. A significant decrease of PKC- total optical density,
measured in gross homogenate, suggests PKC degradation over
time. Similar changes were seen in PKC-, but not in PKC-. OD,
Optical density.
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or ischemic preconditioning, as does the functional response
of myofilaments.12 This suggests that cold cardioplegic
arrest may cause unique changes that should be investigated
separately. There is some evidence that increased intracel-
lular PKC or translocation of some isozymes from one site
to another is associated with phosphorylation of regulatory
contractile proteins (eg, troponin I and troponin T). Specific
changes in the phosphorylated state of these proteins could
be related to depression of ventricular function21 or could
contribute to proteolytic degradation.25,29 However, it is still
unclear which PKC isozymes are predominantly involved
and whether the translocation of PKC isozymes, and any
resulting dysfunctional consequences, can be prevented.
PKC- has recently been identified as playing a critical
role in protecting the myocardium against ischemia/reper-
fusion injury.6,11,26,27 However, the involvement of, and
role for, other PKC isozymes has not been excluded. Evi-
dence indicates that translocation of PKC- from the cytosol
to the myofilaments may be protective.28,29 Support for this
hypothesis has come from independent investigations with
ethanol,26 ischemic preconditioning,16 and cold crystalloid
CDPL supplemented with adenosine.10 Our data demon-
strated a significant increase in PKC- concentration in the
myofilament fraction at 30 and 60 minutes with cold, crys-
talloid St Thomas No. 2 cardioplegia. Previous work from
our laboratory has demonstrated that when adenosine is
added in CDPL solution, translocation of PKC- from the
cytosolic to particulate fractions is enhanced,10 and the
hearts are better protected during the arrest period. These
data are consistent with the hypothesis that PKC- is pro-
tective. However, we also reported that adenosine sup-
pressed the translocation of PKC-. It has been suggested
that activation of PKC- may be detrimental,28 and evi-
dence indicates that activation of PKC can increase the
susceptibility of contractile proteins to proteolytic degrada-
tion.29 The selective, sustained translocation of only the
PKC- isozyme during CDPL agrees with our earlier
work10 and may be involved in this regard. Work to spe-
cifically test the role of PKC- has been limited, however,
by the lack of specific inhibitors that can be used in the
intact organ to concomitantly measure contractile function.
We have tried to use rottlerin to specifically inhibit PKC-,
but the infusion of the compound itself caused severe myo-
cardial depression that would have obscured any functional
assessment (data not shown). Future work is needed to
investigate this important question.
The temporal differences in isozyme translocation spe-
cifically to the cellular fraction containing the myofilament
proteins are novel. These data are consistent with our hy-
pothesis that activation of PKC may contribute to the altered
myofilament function we have shown to occur in this model
of CDPL arrest. The selective translocation of PKC-
isozyme during CDPL agrees with our earlier work and
differs from that seen under other conditions, such as warm
ischemia and ischemic preconditioning. It is clear that the
differential PKC responses related with myocardial protec-
tion during cardiac operations cannot be extrapolated from
the responses seen in other conditions.
References
1. DeBoer DA, Clark RE. Iron chelation in myocardial preservation after
ischemia-reperfusion injury: the importance of pretreatment and tox-
icity. Ann Thorac Surg. 1992;53:412-8.
2. Johnson JA, Mochly-Rosen D. Inhibition of the spontaneous rate of
contraction of neonatal cardiac myocytes by protein kinase C
isozymes. A putative role for the epsilon isozyme. Circ Res. 1995;76:
654-63.
3. Robert V, Ayoub S, Berson G. Effects of hydroxyl radicals on ATPase
and protein structure of myofibrils from rat heart. Am J Physiol.
1991;261:H1785-90.
4. Loop FD, Higgins TL, Panda R, Pearce G, Estafanous G. Myocardial
protection during cardiac operations. J Thorac Cardiovasc Surg. 1992;
104:608-18.
5. Powers FM, Fogelson BG, Sturgeon C, Solaro RJ, Law WR. De-
pressed myofilament cooperativity associated with post-cardioplegic
myocardial depression. J Mol Cell Cardiol. 1998;30:1779-87.
6. Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis
of protein kinase C epsilon signaling complexes in the normal heart
and during cardioprotection. Circ Res. 2001;5:59-62.
7. Lu K, Otani H, Yamamura T, Nakao Y, Hattori R, Ninomiya H, et al.
Protein kinase C isoform-dependent myocardial protection by isch-
emic preconditioning and potassium cardioplegia. J Thorac Cardio-
vasc Surg. 2001;121:137-48.
8. Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK. The role
of protein kinase C in ischemic/reperfused preconditioned isolated rat
hearts. J Cardiovasc Pharmacol. 1996;28:723-31.
9. Mochly-Rosen D, Gordon AS. Anchoring proteins for protein kinase
C: a means for isozyme selectivity. FASEB J. 1998;12:35-42.
10. Nawas SI, Schwertz DW, Beck JM, Fogelson BG, Law WR. Mecha-
nisms of myocardial protection by adenosine-supplemented cardiople-
gia: differential response of calcium-independent protein kinase C
isozymes. J Surg Res. 2000;89:163-8.
11. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase
C-epsilon is responsible for the protection of preconditioning in rabbit
cardiomyocytes. J Mol Cell Cardiol. 1999;31:1937-48.
12. Fogelson BG, Nawas SI, Law WR. Mechanisms of myocardial pro-
tection in adenosine-supplemented cardioplegia: myofilament and
metabolic responses. J Thorac Cardiovasc Surg. 2000;119:601-9.
13. Laemmli UK. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature. 1970;227:680-5.
14. Powers FM, Fogelson BG, Sturgeon C, Solaro RJ, Law WR. De-
pressed myofilament cooperativity associated with post-cardioplegic
myocardial depression. J Mol Cell Cardiol. 1998;30:1779-87.
15. Yoshida K, Hirata T, Akita Y, Mizukama Y, Yamaguchi K, Sorimachi
Y, et al. Translocation of protein kinase C-alpha, delta and epsilon
isoforms in ischemic rat heart. Biochim Biophys Acta. 1996;1317:36-
44.
16. Ping P, Zhang J, Qui Y, Tang X, Manchikalapudi S, Cao X, et al.
Ischemic preconditioning induces selective translocation of protein
kinase C isoforms epsilon and eta in the heart of conscious rabbits
without subcellular redistribution of total protein kinase C activity.
Circ Res. 1997;81:404-14.
17. Jovanovic A, Lopez JR, Alekseev AE, Shen WK, Terzic A. Adenosine
prevents K-induced Ca2loading: insight into cardioprotection dur-
ing cardioplegia. Ann Thorac Surg. 1998;65:586-91.
18. Piper HM, Garcia-Dorado D. Prime causes of rapid cardiomyocyte
death during reperfusion. Ann Thorac Surg. 1999;68:1913-9.
19. Park JL, Lucchesi BR. Mechanism of myocardial reperfusion injury.
Ann Thorac Surg. 1999;68:1905-12.
20. Thourani VH, Ronson RS, Van Wylen DGL, Shearer ST, Katzmark
SL, Zhao Z, et al. Adenosine-supplemented blood cardioplegia atten-
Cardiopulmonary Support and Physiology Jonjev et al
1884 The Journal of Thoracic and Cardiovascular Surgery ● December 2003
CSP
uates postischemic dysfunction after severe regional ischemia. Circu-
lation. 1999;100(suppl 2):376-83.
21. Giles TDN, Ouyang J, Kerut K, Given MB, Allen GE, Mcilwain EF,
et al. Changes in PKC in early cardiomyopathy and in gracilis muscle
in the BB/Wor diabetic rat. Am J Physiol.. 1998;274(1 Pt 2):H295-307.
22. Das DK, Engelman RM, Maulik N. Oxygen free radical signaling in
ischemic preconditioning. Ann N Y Acad Sci. 1999;874:49-65.
23. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen species function
as second messenger during ischemic preconditioning of heart. Mol
Cell Biochem. 1999;196:59-67.
24. Hattori R, Otani H, Uchiyama T, Imamura H, Cui J, Maulik N, et al.
Src tyrosine kinase is the trigger but not the mediator of ischemic
preconditioning. Am J Physiol Heart Circ Physiol. 2001;281:H1066-
74.
25. Tanaka Y, Kashiwagi A, Ogawa T, Abe N, Asahina T, Ikebuchi M, et
al. Effect of verapamil on cardiac protein kinase C activity in diabetic
rats. Eur J Pharmacol. 1991;200:353-6.
26. Chen C, Gray MO, Mochly-Rosen D. Cardioprotection from ischemia
by a brief exposure to physiological levels of ethanol: role of epsilon
protein kinase C. Proc Natl Acad Sci U S A. 1999;96:12784-9.
27. Dorn GW, Souroujon MC, Liron T, Chen C, Gray MO, Zhou H, et al.
Sustained in vivo cardiac protection by a rationally designed peptide
that causes epsilon protein kinase C translocation. Proc Natl Acad Sci
U S A. 1999;96:12798-803.
28. Mochly-Rosen D, Kauvar LM. Modulating protein kinase C signal
transduction. Adv Pharmacol. 1998;44:91-145.
29. Di Lisa F, De Tullio R, Salamino F, Barbato R, Melloni E, Silip-
randi N, et al. Specific degradation of troponin T and I by mu-
calpain and its modulation by substrate phosphorylation. Biochem
J. 1995;308:57-61.
Jonjev et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 6 1885
CS
P
